Verve Therapeutics, Inc. (VERV) Liabilities and Equity USD 2020 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Verve Therapeutics, Inc. quarterly Liabilities and Equity history and growth rate from 2020 to 2024.
Verve Therapeutics, Inc. Liabilities and Equity for the quarter ending March 31, 2024 was $732M, a 15.4% increase year-over-year.

Liabilities and Equity, Quarterly Data (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$732M	+$98M	+15.4%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$753M	+$73.5M	+10.8%	Dec 31, 2023	10-Q	2024-05-08
Q3 2023	$612M	-$60.9M	-9.05%	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$589M	+$265M	+81.7%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$634M	+$285M	+81.6%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$679M	+$295M	+76.8%	Dec 31, 2022	10-K	2024-02-27
Q3 2022	$673M	+$262M	+63.9%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$324M	-$102M	-24%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$349M			Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$384M	+$306M	+390%	Dec 31, 2021	10-K	2023-03-02
Q3 2021	$411M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$427M			Jun 30, 2021	10-Q/A	2021-08-16
Q4 2020	$78.4M			Dec 31, 2020	10-K	2022-03-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.